中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2015年
4期
223-226
,共4页
血液透析%冠心病%残余肾功能%瑞舒伐他汀%临床药师
血液透析%冠心病%殘餘腎功能%瑞舒伐他汀%臨床藥師
혈액투석%관심병%잔여신공능%서서벌타정%림상약사
Hemodialysis%Coronary heart disease%Residual renal function%Rosuvastatin%Clinical pharmacist
1例41岁慢性肾功能不全行血液透析的男性患者,因"发作性胸闷6 d"入院,诊断为冠状动脉粥样硬化性心脏病,不稳定型心绞痛.住院期间给予抗血小板、抗心肌缺血、强化降脂等治疗.临床药师重点关注了治疗冠心病药物对血液透析患者残余肾功能的影响.ACEI/ARB类药物可减缓血液透析患者残余肾功能的下降速度,对残余肾功能具有保护作用.而瑞舒伐他汀钙片因其肾损害的发生率较其他他汀类药物显著增高,建议血液透析患者避免使用.经治疗,患者病情好转,监测肾功能未见进一步降低.
1例41歲慢性腎功能不全行血液透析的男性患者,因"髮作性胸悶6 d"入院,診斷為冠狀動脈粥樣硬化性心髒病,不穩定型心絞痛.住院期間給予抗血小闆、抗心肌缺血、彊化降脂等治療.臨床藥師重點關註瞭治療冠心病藥物對血液透析患者殘餘腎功能的影響.ACEI/ARB類藥物可減緩血液透析患者殘餘腎功能的下降速度,對殘餘腎功能具有保護作用.而瑞舒伐他汀鈣片因其腎損害的髮生率較其他他汀類藥物顯著增高,建議血液透析患者避免使用.經治療,患者病情好轉,鑑測腎功能未見進一步降低.
1례41세만성신공능불전행혈액투석적남성환자,인"발작성흉민6 d"입원,진단위관상동맥죽양경화성심장병,불은정형심교통.주원기간급여항혈소판、항심기결혈、강화강지등치료.림상약사중점관주료치료관심병약물대혈액투석환자잔여신공능적영향.ACEI/ARB류약물가감완혈액투석환자잔여신공능적하강속도,대잔여신공능구유보호작용.이서서벌타정개편인기신손해적발생솔교기타타정류약물현저증고,건의혈액투석환자피면사용.경치료,환자병정호전,감측신공능미견진일보강저.
One 41-year-old male patient with chronic renal inadequacy treated with hemodialysis was admitted into hospital because of onset of chest discomfort for 6 days. The diagnosis was coronary atherosclerotic heart disease, unstable angina pectoris. The patient was given antiplatelet drugs, anti-myocardial ischemia drugs and intensive lipid-lowering therapy in the hospitalization period. Clinical pharmacist paid more attention to the investigation of the drug effects on residual renal function. ACEI/ARB could slower the descending speed of residual renal function for the patient with hemodialysis, and had protective effects on it. The incidence of renal damage by rosuvastatin was signiifcantly higher than that of the other statins, which was suggested to avoid using on the patient with hemodialysis. The patient recovered well after treatment and renal function did not decrease.